DOTAGITA

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug DOTAGITA contains one active pharmaceutical ingredient (API):

1 Gadoteric acid
UNII L0ND3981AG - GADOTERATE MEGLUMINE

Gadoteric acid has paramagnetic properties allowing MRI contrast enhancement. It has no specific pharmacodynamic activity and is biologically very inert.

Read about Gadoteric acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08CA02 Gadoteric acid V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1611526, 1611650, 1611661, 1611672, 1611683, 1611694, 1611706, 1611717, 1611728, 1611739
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1069876, 1074225, 1074226, 1074227, 1074228, 1074229, 1074230, 1074231, 1074232, 1074233

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.